InsidersTradesSigma
Browse the complete record of transactions filed by Sobel Alan D., Director. Director active across 1 companies, notably Cytosorbents Corp. Aggregated, 2 filings have been published. Total volume traded: €2k. The latest transaction was filed on 11 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Alan D. Sobel is a Board Member at Cytosorbents Corp. He contributes to the governance of the company, which specializes in medical technologies. His expertise is valuable in guiding strategic decisions for Cytosorbents.